Name | Tyrphostin B44, (+) enantiomer,(S)-(E)-2-Cyano-3-(3',4'-dihydroxyphenyl)-N-(1-phenylethyl)-2-propenamide |
---|---|
Synonyms |
AG 835
TYRPHOSTIN AG 835 Tyrphostin AG 835 TYRPHOSTIN B50 |
Description | (+)-Tyrphostin B44 (Tyrphostin AG 835) (Compound B50) is an EGRF inhibitor with antitumor activities[1]. |
---|---|
Related Catalog | |
In Vitro | (+)-Tyrphostin B44 (Tyrphostin AG 835) (Compound B50) (0-100 µM) inhibits cell survival with EC50 values of 3.12, 12.5 and 12.5 µM against CALO, INBL and HeLa cells, respectively[1]. |
References |
Density | 1.299g/cm3 |
---|---|
Boiling Point | 603ºC at 760mmHg |
Melting Point | 146 °C |
Molecular Formula | C18H16N2O3 |
Molecular Weight | 308.33100 |
Flash Point | 318.5ºC |
Exact Mass | 308.11600 |
PSA | 93.35000 |
LogP | 3.27308 |
Vapour Pressure | 3.9E-15mmHg at 25°C |
Index of Refraction | 1.66 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | S22 |
RIDADR | NONH for all modes of transport |